ABOS vs XXII

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

ABOS

43.3
AI Score
VS
XXII Wins

XXII

49.0
AI Score

Investment Advisor Scores

ABOS

43score
Recommendation
HOLD

XXII

49score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABOS XXII Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -43.3% ABOS
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 43.3/100 49.0/100 XXII
Profit Margin 0.0% -65.8% ABOS
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ABOS 1M: -17.8% · 3M: -11.5% XXII 1M: -2.2% · 3M: +321.9%

Current Technical Phase

ABOS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.1%), weak momentum, RSI 45

RSI (14): 44.6 · Price: $2.20

XXII

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (63.2% over 20 days), RSI 54

RSI (14): 53.7 · Price: $4.19

Fundamentals Snapshot

Metric ABOS XXII
Market Cap
Forward P/E -1.5 0.0
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -0.4%
Gross Margin -318.9% -0.5%
Operating Margin 0.0% -2.4%
EPS -1.86 -650.73
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XXII is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.